Entrada Therapeutics, Inc. (TRDA)
6.84
-0.01
(-0.15%)
USD |
NASDAQ |
May 08, 16:00
6.76
-0.08
(-1.17%)
After-Hours: 20:00
Entrada Therapeutics Shareholders Equity (Quarterly) : 270.85M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 19.36B |
| Tyra Biosciences, Inc. | 259.18M |
| Biogen, Inc. | 18.65B |
| Catalyst Pharmaceuticals, Inc. | 954.27M |
| XOMA Royalty Corp. | 103.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 335.52M |
| Total Liabilities (Quarterly) | 64.66M |
| Debt to Equity Ratio | 0.1837 |
| Current Ratio | 13.90 |
| Net Debt Paydown Yield | 0.39% |